Villan, Raymundo E.

HRN: 28-85-16  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/12/2026
04/18/2026
IV INFUSION
2.25
Q8
Cap HR T/c Sepsis, (continuation Of Treatment)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: